Which factors are associated with bone marrow oedema suspicious of axial spondyloarthritis as detected by MRI in the sacroiliac joints and the spine in the general population?
10.1136/annrheumdis-2020-218669
November 25, 2020
Spondyloarthritis
Axial involvement in patients with early peripheral spondyloarthritis: a prospective MRI study of sacroiliac joints and spine
10.1136/annrheumdis-2020-218480
October 28, 2020
Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence
10.1136/annrheumdis-2019-216741
July 13, 2020
Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort
10.1136/annrheumdis-2019-215934
June 24, 2020
MRI of sacroiliac joints for the diagnosis of axial SpA: prevalence of inflammatory and structural lesions in nulliparous, early postpartum and late postpartum women
10.1136/annrheumdis-2020-217208
June 10, 2020
Outcomes and treatment responses, including work productivity, among people with axial spondyloarthritis living in urban and rural areas: a mixed-methods study within a national register
10.1136/annrheumdis-2020-216988
June 10, 2020
Normal human enthesis harbours conventional CD4+ and CD8+ T cells with regulatory features and inducible IL-17A and TNF expression
10.1136/annrheumdis-2020-217309
May 13, 2020
Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction
10.1136/annrheumdis-2019-216839
May 7, 2020
Central reader evaluation of MRI scans of the sacroiliac joints from the ASAS classification cohort: discrepancies with local readers and impact on the performance of the ASAS criteria
10.1136/annrheumdis-2020-217232
May 5, 2020
Real-world evidence of TNF inhibition in axial spondyloarthritis: can we generalise the results from clinical trials?
10.1136/annrheumdis-2019-216841
April 23, 2020